반응식
Cl[C:2]1[CH:3]=[C:4](C(O)CN)[CH:5]=[CH:6][CH:7]=1.[F:12][C:13]1[CH:14]=[C:15]([CH:19]([OH:22])[CH2:20][NH2:21])[CH:16]=[CH:17][CH:18]=1.[C:23](O)(=O)/[CH:24]=[CH:25]/[C:26](O)=O>>[CH3:23][C:24]1[CH:3]=[CH:2][C:7]([CH2:6][CH:5]([NH:21][CH2:20][CH:19]([OH:22])[C:15]2[CH:16]=[CH:17][CH:18]=[C:13]([F:12])[CH:14]=2)[CH3:4])=[CH:26][CH:25]=1참가 물질
4
실험 절차
The title compound was prepared in the manner described in Example 3 replacing 2-(3-chlorophenyl)-2-hydroxyethanamine with 2-(3-fluorophenyl)-2-hydroxyethanamine. The chromatographed material was treated with methanolic fumaric acid and the derived salt recrystallised from ethyl acetate to give the title compound (fumarate), mp 58-83, as a 52-48 mixture of diastereoisomers.
후처리
- customThe title compound was prepared in the manner
- customthe derived salt recrystallised from ethyl acetate
출처 및 근거
- ORD 기록
- ord-cae322d37bd94ec9aae0e1baf9fe6a28
- 출처 데이터셋
- uspto-grants-1986_05
- 특허 번호
- US04588749
연결된 노트
불러오는 중…